Pfizer Inc. settles deceptive co-pay coupon class in New York

Pfizer Inc. settled a case brought by New York’s attorney general based on the company’s misleading consumers with its drug co-payment coupon program. Pfizer’s agreed to pay $500,000 in fines and costs and to issue more than $200,000 in new restitution coupons to consumers. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.